Your browser doesn't support javascript.
loading
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.
Garcia-Vidal, Carolina; Alonso, Rodrigo; Camon, Ana M; Cardozo, Celia; Albiach, Laia; Agüero, Daiana; Marcos, M Angeles; Ambrosioni, Juan; Bodro, Marta; Chumbita, Mariana; de la Mora, Lorena; Garcia-Pouton, Nicole; Dueñas, Gerard; Hernandez-Meneses, Marta; Inciarte, Alexy; Cuesta, Genoveva; Meira, Fernanda; Morata, Laura; Puerta-Alcalde, Pedro; Herrera, Sabina; Tuset, Montse; Castro, Pedro; Prieto-Gonzalez, Sergio; Almuedo-Riera, Alex; Mensa, Josep; Martínez, José Antonio; Sanjuan, Gemma; Nicolas, J M; Del Rio, A; Muñoz, José; Vila, Jordi; Garcia, Felipe; Soriano, Alex.
Afiliación
  • Garcia-Vidal C; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Alonso R; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Camon AM; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Cardozo C; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Albiach L; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Agüero D; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Marcos MA; Department of Microbiology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Ambrosioni J; Institute for Global Health (ISGlobal), Barcelona, Spain.
  • Bodro M; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Chumbita M; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • de la Mora L; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Garcia-Pouton N; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Dueñas G; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Hernandez-Meneses M; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Inciarte A; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Cuesta G; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Meira F; Department of Microbiology, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Morata L; Institute for Global Health (ISGlobal), Barcelona, Spain.
  • Puerta-Alcalde P; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Herrera S; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Tuset M; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Castro P; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Prieto-Gonzalez S; Department of Pharmacy, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Almuedo-Riera A; Medical Intensive Care Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Mensa J; Department of Internal Medicine, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Martínez JA; Institute for Global Health (ISGlobal), Barcelona, Spain.
  • Sanjuan G; Department of International Health, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Nicolas JM; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Del Rio A; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Muñoz J; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Vila J; Computer System Unit, Hospital Clinic, Barcelona, Spain.
  • Garcia F; Medical Intensive Care Unit, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Soriano A; Department of Infectious Diseases, Hospital Clinic of Barcelona-IDIBAPS, University of Barcelona, Barcelona, Spain.
J Antimicrob Chemother ; 76(12): 3296-3302, 2021 11 12.
Article en En | MEDLINE | ID: mdl-34473275
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_covid_19 Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: España
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD Problema de salud: 4_covid_19 Asunto principal: Tratamiento Farmacológico de COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: España